Paul Tudor Jones Adma Biologics, Inc. Transaction History
Tudor Investment Corp Et Al
- $26.8 Billion
- Q3 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 10,745 shares of ADMA stock, worth $192,335. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,745
Previous 12,122
11.36%
Holding current value
$192,335
Previous $135,000
58.52%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding ADMA
# of Institutions
319Shares Held
184MCall Options Held
917KPut Options Held
91.6K-
Black Rock Inc. New York, NY18.6MShares$334 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.1MShares$324 Million0.01% of portfolio
-
State Street Corp Boston, MA13MShares$233 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.6MShares$226 Million0.05% of portfolio
-
Morgan Stanley New York, NY8.6MShares$154 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.51B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...